Clinical Trials Related to Bristol-Myers Squibb

Related studies linked through entity extraction aliases.

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Status: WITHDRAWN
Phase: PHASE2

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Status: COMPLETED
Phase: PHASE1

Safety Study of Abatacept in Rheumatoid Arthritis Participants

Status: COMPLETED
Phase: N/A

A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma

Status: COMPLETED
Phase: N/A

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma

Status: TERMINATED
Phase: NA

Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia

Status: COMPLETED
Phase: PHASE2

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Status: COMPLETED
Phase: PHASE3

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic

Status: TERMINATED
Phase: PHASE2

Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma

Status: UNKNOWN
Phase: PHASE1/PHASE2

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

Status: RECRUITING
Phase: PHASE1/PHASE2

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Status: COMPLETED
Phase: PHASE2

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Status: COMPLETED
Phase: PHASE1

A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

Status: COMPLETED
Phase: N/A

Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Safety and Efficacy of Abatacept in IgG4-Related Disease

Status: COMPLETED
Phase: PHASE2

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Status: COMPLETED
Phase: PHASE2

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Status: COMPLETED
Phase: PHASE1

A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

Status: COMPLETED
Phase: N/A